Gastrointestinal means pertaining to the intestines and stomach. A tract is a group of anatomic structures or a sequence of associated body organs. Gastrointestinal disease refers to diseases that involve gastrointestinal tract such as the stomach, esophagus, small intestine, rectum, and the large intestine. It can also be related to other organs of digestion such as the liver, pancreas, and the gallbladder. The GI or gastrointestinal tract (also known as GI tract, alimentary canal, digestive tract, GIT, or gut) is the organ system within the human body as well as other animals which can take in food, digest it and absorb essential nutrients and energy, and excretes the waste as urine and feces. All bilaterians (animals having a bilateral symmetry) have a GI tract. Primarily, it is a tube that can transfer food to various organs of digestion. In case of large bilaterians, the alimentary canal generally has an exit, by which the animal is able to dispose of feces. However, some bilaterians that are small in size have no exit or opening and they dispose of solid wastes by mouth or other means.
Get PDF Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/185
Gastrointestinal devices used to examine the internal lining of the GI tract are termed as gastrointestinal devices. An infection or abnormality in the basic functioning of this gastrointestinal tract is identified by gastrointestinal devices. The device is useful for detecting the root cause of many ailments concerning the gastrointestinal tract, such as vomiting, abdominal bleeding, persistent pain, tumor, and inflammation that affects the esophagus, stomach, and duodenum. In addition to detection, gastrointestinal devices also help in treating these diseases. Gastroesophageal reflux disease, colon cancer, ulcer, hemorrhoids, diverticulitis, Crohn’s disease, and bowel syndrome are some of the examples GI disease. Higher prevalence of these diseases due to high consumption of fast food and sedentary lifestyle are projected to drive growth of the overall gastrointestinal devices market.
Increasing prevalence of gastroesophageal reflux disease and increase in colorectal cancer to drive growth of the overall gastrointestinal devices market
According to a report published by Healthline in 2012, pregnant women and persons above the age of 40 years are at a higher risk of gastroesophageal disease. The report further states that 25% of pregnant women experience symptoms of the disease, and it increases with time. Around 65% of patients who suffer from acid refluxes are 40 years of age or older. The occurrence of gastroesophageal reflux disease, especially in North America is growing at an alarming rate. This is mainly attributed to the sedentary lifestyle and high consumption of fast food in the region. According to the American Cancer Society, in 2017, colorectal cancer is expected to lead to 50,260 deaths in the U.S. Therefore, the gastrointestinal devices market in this region is expected to grow at a significant rate over the forecast period.
Some of the companies operating in the gastrointestinal devices market in the current scenario are Boston Scientific Corporation, Johnson & Johnson Ltd., Covidien Ltd., Fujinon Ltd., Stryker Corporation, Conmed Corporation, Medtronic, Karl Storz, and Olympus Corporation.
Gastrointestinal Devices Market Taxonomy
On the basis of product type, the global market is classified into:
On the basis of end user, the global market is classified into:
Ambulatory Surgical Centers
Click To Continue Reading On Gastrointestinal Devices Market Analysis
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154